These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 30145124)
21. Prevalence of and factors associated with postural deformities in Chinese patients with multiple system atrophy. Zhang L; Cao B; Zou Y; Wei QQ; Ou R; Zhao B; Yang J; Wu Y; Shang H Parkinsonism Relat Disord; 2019 Jul; 64():324-327. PubMed ID: 30987897 [TBL] [Abstract][Full Text] [Related]
22. Frontal lobe function, behavioral changes and quality of life in patients with multiple system atrophy. Zhang L; Cao B; Zou Y; Wei QQ; Ou R; Zhao B; Yang J; Wu Y; Shang H Restor Neurol Neurosci; 2019; 37(1):11-19. PubMed ID: 30741706 [TBL] [Abstract][Full Text] [Related]
24. Blood-brain barrier impairment is functionally correlated with clinical severity in patients of multiple system atrophy. Song SK; Lee SK; Lee JJ; Lee JE; Choi HS; Sohn YH; Lee PH Neurobiol Aging; 2011 Dec; 32(12):2183-9. PubMed ID: 20149484 [TBL] [Abstract][Full Text] [Related]
25. Inosine 5'-Monophosphate to Raise Serum Uric Acid Level in Multiple System Atrophy (IMPROVE-MSA study). Jung Lee J; Han Yoon J; Jin Kim S; Soo Yoo H; Jong Chung S; Hyun Lee Y; Yun Kang S; Shin HW; Keun Song S; Yong Hong J; Sunwoo M; Eun Lee J; Sam Baik J; Sohn YH; Hyu Lee P Clin Pharmacol Ther; 2021 May; 109(5):1274-1281. PubMed ID: 33064299 [TBL] [Abstract][Full Text] [Related]
26. Motor assessment of patients with multiple system atrophy: underuse of the Unified Multiple System Atrophy Rating Scale (UMSARS). Ferreirós A; Castillo-Torres SA; Merello M Clin Auton Res; 2023 Apr; 33(2):143-148. PubMed ID: 36971870 [TBL] [Abstract][Full Text] [Related]
27. Impaired glymphatic clearance in multiple system atrophy: A diffusion spectrum imaging study. Shi C; Guo G; Wang W; Yu H; Fan H; Wu P; Song P; Gong D Parkinsonism Relat Disord; 2024 Jun; 123():106950. PubMed ID: 38555791 [TBL] [Abstract][Full Text] [Related]
28. Oxidative Stress and Environmental Exposures are Associated with Multiple System Atrophy in Chinese Patients. Zhou L; Jiang Y; Zhu C; Ma L; Huang Q; Chen X Can J Neurol Sci; 2016 Sep; 43(5):703-9. PubMed ID: 27670212 [TBL] [Abstract][Full Text] [Related]
29. Cerebral atrophy in multiple system atrophy by MRI. Horimoto Y; Aiba I; Yasuda T; Ohkawa Y; Katayama T; Yokokawa Y; Goto A; Ito Y J Neurol Sci; 2000 Feb; 173(2):109-12. PubMed ID: 10675653 [TBL] [Abstract][Full Text] [Related]
30. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Lee PH; Kim JW; Bang OY; Ahn YH; Joo IS; Huh K Clin Pharmacol Ther; 2008 May; 83(5):723-30. PubMed ID: 17898702 [TBL] [Abstract][Full Text] [Related]
31. Hypothalamic involvement in multiple system atrophy: A structural MRI study. Pasquini J; Firbank MJ; Best L; Foster V; Galley D; Silani V; Ceravolo R; Petrides G; Brooks DJ; Anderson KN; Pavese N J Neurol Sci; 2024 May; 460():122985. PubMed ID: 38581741 [TBL] [Abstract][Full Text] [Related]
32. Alterations in Resting-State MR Functional Connectivity of the Central Autonomic Network in Multiple System Atrophy and Relationship with Disease Severity. Lyu H; Zhu X; He N; Li Q; Yin Q; Huang Y; Yan F; Liu J; Lu Y J Magn Reson Imaging; 2023 Nov; 58(5):1472-1487. PubMed ID: 36988420 [TBL] [Abstract][Full Text] [Related]
33. MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects. Paviour DC; Price SL; Lees AJ; Fox NC J Neurol; 2007 Apr; 254(4):478-81. PubMed ID: 17401522 [TBL] [Abstract][Full Text] [Related]
34. Retinal thinning correlates with clinical severity in multiple system atrophy. Ahn J; Lee JY; Kim TW J Neurol; 2016 Oct; 263(10):2039-47. PubMed ID: 27416856 [TBL] [Abstract][Full Text] [Related]
35. Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study. Zhang L; Hou Y; Cao B; Wei Q; Ou R; Liu K; Lin J; Yang T; Xiao Y; Chen Y; Song W; Zhao B; Shang H BMC Med; 2022 Nov; 20(1):446. PubMed ID: 36397048 [TBL] [Abstract][Full Text] [Related]
36. Factors impacting quality of life in multiple system atrophy. Ali N; Nesspor V; Bang J; Scholz SW; Pantelyat A Front Neurol; 2023; 14():1111605. PubMed ID: 36970533 [TBL] [Abstract][Full Text] [Related]
37. Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Seppi K; Schocke MF; Mair KJ; Esterhammer R; Scherfler C; Geser F; Kremser C; Boesch S; Jaschke W; Poewe W; Wenning GK Neuroimage; 2006 May; 31(1):240-5. PubMed ID: 16443375 [TBL] [Abstract][Full Text] [Related]
38. Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time. Damon-Perrière N; Foubert-Samier A; De Cock VC; Gerdelat-Mas A; Debs R; Pavy-Le Traon A; Senard JM; Rascol O; Tison F; Meissner WG Parkinsonism Relat Disord; 2012 Jun; 18(5):612-5. PubMed ID: 22236582 [TBL] [Abstract][Full Text] [Related]
39. An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale. Foubert-Samier A; Pavy-Le Traon A; Saulnier T; Le-Goff M; Fabbri M; Helmer C; Rascol O; Proust-Lima C; Meissner WG Parkinsonism Relat Disord; 2022 Jan; 94():40-44. PubMed ID: 34875563 [TBL] [Abstract][Full Text] [Related]
40. Self-reported urinary impairment identifies 'fast progressors' in terms of neuronal loss in multiple system atrophy. Guevara C; de Grazia J; Baabor P; Soruco W Auton Neurosci; 2019 Mar; 217():1-6. PubMed ID: 30704970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]